nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—ABCB1—Parkinson's disease	0.694	1	CbGaD
Scopolamine—SI—embryo—Parkinson's disease	0.00988	0.137	CbGeAlD
Scopolamine—SI—head—Parkinson's disease	0.005	0.0693	CbGeAlD
Scopolamine—SI—nervous system—Parkinson's disease	0.00474	0.0657	CbGeAlD
Scopolamine—SI—central nervous system—Parkinson's disease	0.00457	0.0633	CbGeAlD
Scopolamine—SI—brain—Parkinson's disease	0.00362	0.0502	CbGeAlD
Scopolamine—CHRM4—head—Parkinson's disease	0.00247	0.0342	CbGeAlD
Scopolamine—CHRM4—nervous system—Parkinson's disease	0.00234	0.0325	CbGeAlD
Scopolamine—CHRM2—forebrain—Parkinson's disease	0.00231	0.0321	CbGeAlD
Scopolamine—CHRM4—central nervous system—Parkinson's disease	0.00225	0.0313	CbGeAlD
Scopolamine—CHRM1—forebrain—Parkinson's disease	0.00211	0.0292	CbGeAlD
Scopolamine—CHRM2—cardiovascular system—Parkinson's disease	0.00196	0.0271	CbGeAlD
Scopolamine—CHRM5—head—Parkinson's disease	0.00193	0.0268	CbGeAlD
Scopolamine—CHRM3—forebrain—Parkinson's disease	0.00189	0.0261	CbGeAlD
Scopolamine—CHRM5—nervous system—Parkinson's disease	0.00183	0.0254	CbGeAlD
Scopolamine—CHRM4—brain—Parkinson's disease	0.00179	0.0248	CbGeAlD
Scopolamine—CHRM1—cardiovascular system—Parkinson's disease	0.00178	0.0247	CbGeAlD
Scopolamine—CHRM5—central nervous system—Parkinson's disease	0.00176	0.0244	CbGeAlD
Scopolamine—CHRM5—brain—Parkinson's disease	0.0014	0.0194	CbGeAlD
Scopolamine—CHRM2—head—Parkinson's disease	0.00133	0.0184	CbGeAlD
Scopolamine—CHRM2—nervous system—Parkinson's disease	0.00126	0.0174	CbGeAlD
Scopolamine—CHRM2—central nervous system—Parkinson's disease	0.00121	0.0168	CbGeAlD
Scopolamine—CHRM1—head—Parkinson's disease	0.00121	0.0167	CbGeAlD
Scopolamine—CHRM1—nervous system—Parkinson's disease	0.00114	0.0159	CbGeAlD
Scopolamine—CHRM1—central nervous system—Parkinson's disease	0.0011	0.0153	CbGeAlD
Scopolamine—CHRM3—head—Parkinson's disease	0.00108	0.015	CbGeAlD
Scopolamine—CHRM3—nervous system—Parkinson's disease	0.00102	0.0142	CbGeAlD
Scopolamine—CHRM3—central nervous system—Parkinson's disease	0.000985	0.0137	CbGeAlD
Scopolamine—CHRM2—brain—Parkinson's disease	0.00096	0.0133	CbGeAlD
Scopolamine—CHRM1—brain—Parkinson's disease	0.000874	0.0121	CbGeAlD
Scopolamine—ABCB1—embryo—Parkinson's disease	0.000829	0.0115	CbGeAlD
Scopolamine—CHRM3—brain—Parkinson's disease	0.000782	0.0108	CbGeAlD
Scopolamine—ABCB1—forebrain—Parkinson's disease	0.000733	0.0102	CbGeAlD
Scopolamine—ABCB1—cardiovascular system—Parkinson's disease	0.00062	0.0086	CbGeAlD
Scopolamine—ABCB1—medulla oblongata—Parkinson's disease	0.00053	0.00734	CbGeAlD
Scopolamine—ABCB1—midbrain—Parkinson's disease	0.000484	0.00671	CbGeAlD
Scopolamine—ABCB1—spinal cord—Parkinson's disease	0.000473	0.00655	CbGeAlD
Scopolamine—ABCB1—head—Parkinson's disease	0.00042	0.00582	CbGeAlD
Scopolamine—ABCB1—nervous system—Parkinson's disease	0.000398	0.00552	CbGeAlD
Scopolamine—ABCB1—central nervous system—Parkinson's disease	0.000383	0.00531	CbGeAlD
Scopolamine—ABCB1—cerebellum—Parkinson's disease	0.000375	0.00519	CbGeAlD
Scopolamine—ABCB1—brain—Parkinson's disease	0.000304	0.00422	CbGeAlD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—TNF—Parkinson's disease	8.68e-05	0.000371	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GRK5—Parkinson's disease	8.55e-05	0.000366	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—EDN1—Parkinson's disease	8.54e-05	0.000366	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—NDUFB11—Parkinson's disease	8.54e-05	0.000365	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GRK5—Parkinson's disease	8.53e-05	0.000365	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	8.51e-05	0.000364	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—HTR1A—Parkinson's disease	8.48e-05	0.000363	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GRK5—Parkinson's disease	8.44e-05	0.000361	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—DDC—Parkinson's disease	8.4e-05	0.000359	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—HTR1A—Parkinson's disease	8.4e-05	0.000359	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—TAC1—Parkinson's disease	8.38e-05	0.000359	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—TAC1—Parkinson's disease	8.35e-05	0.000357	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—TAC1—Parkinson's disease	8.27e-05	0.000354	CbGpPWpGaD
Scopolamine—SI—Disease—IL6—Parkinson's disease	8.24e-05	0.000353	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—DRD1—Parkinson's disease	8.21e-05	0.000352	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—DRD1—Parkinson's disease	8.19e-05	0.00035	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—EDN1—Parkinson's disease	8.18e-05	0.00035	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GCH1—Parkinson's disease	8.15e-05	0.000349	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—DRD1—Parkinson's disease	8.11e-05	0.000347	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—FGF20—Parkinson's disease	8.04e-05	0.000344	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—DRD3—Parkinson's disease	7.96e-05	0.000341	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—DRD3—Parkinson's disease	7.93e-05	0.000339	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GSTA4—Parkinson's disease	7.93e-05	0.000339	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—DRD3—Parkinson's disease	7.85e-05	0.000336	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—ADORA2A—Parkinson's disease	7.8e-05	0.000334	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	7.79e-05	0.000334	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—EDN1—Parkinson's disease	7.76e-05	0.000332	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—HTR1A—Parkinson's disease	7.72e-05	0.000331	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—FGF20—Parkinson's disease	7.7e-05	0.00033	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—HTR1A—Parkinson's disease	7.7e-05	0.00033	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GRM4—Parkinson's disease	7.67e-05	0.000328	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GRM4—Parkinson's disease	7.65e-05	0.000327	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—HTR1A—Parkinson's disease	7.62e-05	0.000326	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—TAC1—Parkinson's disease	7.61e-05	0.000326	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—TAC1—Parkinson's disease	7.58e-05	0.000325	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GRM4—Parkinson's disease	7.57e-05	0.000324	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—TAC1—Parkinson's disease	7.51e-05	0.000321	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—HTR2A—Parkinson's disease	7.47e-05	0.00032	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ADORA2A—Parkinson's disease	7.47e-05	0.00032	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—DRD1—Parkinson's disease	7.46e-05	0.000319	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—DRD1—Parkinson's disease	7.44e-05	0.000318	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—EDN1—Parkinson's disease	7.43e-05	0.000318	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	7.43e-05	0.000318	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—ADRBK1—Parkinson's disease	7.41e-05	0.000317	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—DRD1—Parkinson's disease	7.36e-05	0.000315	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—ADRBK1—Parkinson's disease	7.33e-05	0.000314	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PENK—Parkinson's disease	7.27e-05	0.000311	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MAG—Parkinson's disease	7.27e-05	0.000311	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—DBH—Parkinson's disease	7.26e-05	0.000311	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—FBP1—Parkinson's disease	7.26e-05	0.000311	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GBA—Parkinson's disease	7.26e-05	0.000311	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PENK—Parkinson's disease	7.25e-05	0.00031	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MAG—Parkinson's disease	7.25e-05	0.00031	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—DRD3—Parkinson's disease	7.22e-05	0.000309	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—DRD3—Parkinson's disease	7.2e-05	0.000308	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—INSR—Parkinson's disease	7.2e-05	0.000308	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—DRD2—Parkinson's disease	7.19e-05	0.000308	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—HTR7—Parkinson's disease	7.19e-05	0.000308	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PENK—Parkinson's disease	7.18e-05	0.000307	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MAG—Parkinson's disease	7.18e-05	0.000307	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—DRD2—Parkinson's disease	7.17e-05	0.000307	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—HTR7—Parkinson's disease	7.17e-05	0.000307	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—HTR2A—Parkinson's disease	7.16e-05	0.000306	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PLA2G6—Parkinson's disease	7.14e-05	0.000306	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—DRD3—Parkinson's disease	7.13e-05	0.000305	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—DRD2—Parkinson's disease	7.1e-05	0.000304	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—HTR7—Parkinson's disease	7.1e-05	0.000304	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—MAOB—Parkinson's disease	7.07e-05	0.000303	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	7e-05	0.0003	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—INSR—Parkinson's disease	6.89e-05	0.000295	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—FGB—Parkinson's disease	6.8e-05	0.000291	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—HTR2A—Parkinson's disease	6.79e-05	0.00029	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HTR1A—Parkinson's disease	6.77e-05	0.00029	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	6.75e-05	0.000289	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—ADRBK1—Parkinson's disease	6.72e-05	0.000288	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TAC1—Parkinson's disease	6.66e-05	0.000285	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—ADRBK1—Parkinson's disease	6.66e-05	0.000285	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PDYN—Parkinson's disease	6.65e-05	0.000285	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PDYN—Parkinson's disease	6.63e-05	0.000284	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PDYN—Parkinson's disease	6.57e-05	0.000281	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—DRD1—Parkinson's disease	6.54e-05	0.00028	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—DRD2—Parkinson's disease	6.53e-05	0.00028	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—HTR7—Parkinson's disease	6.53e-05	0.00028	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—FGB—Parkinson's disease	6.51e-05	0.000279	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—DRD2—Parkinson's disease	6.51e-05	0.000279	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—HTR7—Parkinson's disease	6.51e-05	0.000279	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	6.5e-05	0.000278	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—HTR2A—Parkinson's disease	6.5e-05	0.000278	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HTR1A—Parkinson's disease	6.48e-05	0.000277	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—DRD2—Parkinson's disease	6.45e-05	0.000276	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—HTR7—Parkinson's disease	6.45e-05	0.000276	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TAC1—Parkinson's disease	6.38e-05	0.000273	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	6.34e-05	0.000272	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—DRD3—Parkinson's disease	6.33e-05	0.000271	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—DRD1—Parkinson's disease	6.26e-05	0.000268	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GFAP—Parkinson's disease	6.25e-05	0.000268	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GFAP—Parkinson's disease	6.23e-05	0.000267	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GRM5—Parkinson's disease	6.18e-05	0.000265	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GFAP—Parkinson's disease	6.17e-05	0.000264	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GRM5—Parkinson's disease	6.16e-05	0.000264	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GRM5—Parkinson's disease	6.1e-05	0.000261	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	6.09e-05	0.000261	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—DRD3—Parkinson's disease	6.06e-05	0.000259	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	5.98e-05	0.000256	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—ADRBK1—Parkinson's disease	5.91e-05	0.000253	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—IL6—Parkinson's disease	5.79e-05	0.000248	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—EDN1—Parkinson's disease	5.76e-05	0.000247	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—EDN1—Parkinson's disease	5.74e-05	0.000246	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HTR7—Parkinson's disease	5.72e-05	0.000245	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—DRD2—Parkinson's disease	5.72e-05	0.000245	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—EDN1—Parkinson's disease	5.69e-05	0.000243	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ADRBK1—Parkinson's disease	5.66e-05	0.000242	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	5.49e-05	0.000235	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—DRD2—Parkinson's disease	5.48e-05	0.000235	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HTR7—Parkinson's disease	5.48e-05	0.000235	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	5.47e-05	0.000234	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—FGF20—Parkinson's disease	5.42e-05	0.000232	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—FGF20—Parkinson's disease	5.41e-05	0.000231	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—FGF20—Parkinson's disease	5.35e-05	0.000229	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—DDC—Parkinson's disease	5.33e-05	0.000228	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	5.29e-05	0.000227	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ADORA2A—Parkinson's disease	5.26e-05	0.000225	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CYP2D6—Parkinson's disease	5.25e-05	0.000225	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ADORA2A—Parkinson's disease	5.24e-05	0.000224	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—EDN1—Parkinson's disease	5.23e-05	0.000224	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—EDN1—Parkinson's disease	5.21e-05	0.000223	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ADORA2A—Parkinson's disease	5.19e-05	0.000222	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—EDN1—Parkinson's disease	5.16e-05	0.000221	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CTGF—Parkinson's disease	5.16e-05	0.000221	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	5.04e-05	0.000216	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GSTA4—Parkinson's disease	5.03e-05	0.000215	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—HTR2A—Parkinson's disease	5.02e-05	0.000215	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	4.97e-05	0.000213	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—INSR—Parkinson's disease	4.85e-05	0.000208	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—INSR—Parkinson's disease	4.84e-05	0.000207	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CYP2E1—Parkinson's disease	4.8e-05	0.000206	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IGF2—Parkinson's disease	4.8e-05	0.000205	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—INSR—Parkinson's disease	4.79e-05	0.000205	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—NQO1—Parkinson's disease	4.75e-05	0.000203	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	4.73e-05	0.000202	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—TH—Parkinson's disease	4.68e-05	0.0002	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IGF1R—Parkinson's disease	4.64e-05	0.000199	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IGF2—Parkinson's disease	4.59e-05	0.000197	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—FGB—Parkinson's disease	4.59e-05	0.000196	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—EDN1—Parkinson's disease	4.58e-05	0.000196	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	4.58e-05	0.000196	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—FGB—Parkinson's disease	4.57e-05	0.000196	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	4.56e-05	0.000195	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—HTR2A—Parkinson's disease	4.56e-05	0.000195	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HTR1A—Parkinson's disease	4.55e-05	0.000195	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PLA2G6—Parkinson's disease	4.53e-05	0.000194	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—FGB—Parkinson's disease	4.53e-05	0.000194	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	4.52e-05	0.000193	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	4.5e-05	0.000193	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CYCS—Parkinson's disease	4.5e-05	0.000192	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	4.49e-05	0.000192	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—MAOB—Parkinson's disease	4.49e-05	0.000192	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TAC1—Parkinson's disease	4.48e-05	0.000192	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IGF1R—Parkinson's disease	4.44e-05	0.00019	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	4.44e-05	0.00019	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	4.41e-05	0.000189	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—DRD1—Parkinson's disease	4.39e-05	0.000188	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—EDN1—Parkinson's disease	4.39e-05	0.000188	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	4.35e-05	0.000186	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	4.27e-05	0.000183	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—DRD3—Parkinson's disease	4.25e-05	0.000182	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	4.21e-05	0.00018	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NGF—Parkinson's disease	4.21e-05	0.00018	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NGF—Parkinson's disease	4.03e-05	0.000173	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HTR2A—Parkinson's disease	4.01e-05	0.000172	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	3.99e-05	0.000171	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—COMT—Parkinson's disease	3.98e-05	0.00017	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ADRBK1—Parkinson's disease	3.97e-05	0.00017	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GSTP1—Parkinson's disease	3.96e-05	0.00017	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—MAOA—Parkinson's disease	3.95e-05	0.000169	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	3.93e-05	0.000168	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—HMOX1—Parkinson's disease	3.91e-05	0.000167	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	3.86e-05	0.000165	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	3.86e-05	0.000165	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—DRD2—Parkinson's disease	3.85e-05	0.000165	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HTR7—Parkinson's disease	3.85e-05	0.000165	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HTR2A—Parkinson's disease	3.84e-05	0.000164	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	3.81e-05	0.000163	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	3.81e-05	0.000163	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ABCB1—Parkinson's disease	3.75e-05	0.000161	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—APOE—Parkinson's disease	3.73e-05	0.00016	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GSTM1—Parkinson's disease	3.64e-05	0.000156	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—APOE—Parkinson's disease	3.57e-05	0.000153	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GPX1—Parkinson's disease	3.49e-05	0.000149	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYP2D6—Parkinson's disease	3.33e-05	0.000143	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CTGF—Parkinson's disease	3.27e-05	0.00014	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	3.23e-05	0.000138	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	3.22e-05	0.000138	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—MTHFR—Parkinson's disease	3.22e-05	0.000138	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	3.19e-05	0.000137	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—INS—Parkinson's disease	3.18e-05	0.000136	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	3.13e-05	0.000134	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	3.12e-05	0.000133	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	3.09e-05	0.000132	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	3.09e-05	0.000132	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	3.08e-05	0.000132	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	3.05e-05	0.000131	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—INS—Parkinson's disease	3.05e-05	0.000131	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYP2E1—Parkinson's disease	3.05e-05	0.00013	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—NQO1—Parkinson's disease	3.01e-05	0.000129	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—APOE—Parkinson's disease	3e-05	0.000128	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—TH—Parkinson's disease	2.97e-05	0.000127	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYCS—Parkinson's disease	2.85e-05	0.000122	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NGF—Parkinson's disease	2.84e-05	0.000122	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NGF—Parkinson's disease	2.83e-05	0.000121	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NGF—Parkinson's disease	2.8e-05	0.00012	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	2.7e-05	0.000116	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	2.69e-05	0.000115	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	2.67e-05	0.000114	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—INS—Parkinson's disease	2.56e-05	0.00011	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—COMT—Parkinson's disease	2.53e-05	0.000108	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GSTP1—Parkinson's disease	2.51e-05	0.000108	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—APOE—Parkinson's disease	2.51e-05	0.000108	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—MAOA—Parkinson's disease	2.51e-05	0.000107	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—APOE—Parkinson's disease	2.51e-05	0.000107	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—APOE—Parkinson's disease	2.48e-05	0.000106	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—HMOX1—Parkinson's disease	2.48e-05	0.000106	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CASP3—Parkinson's disease	2.37e-05	0.000101	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—IL6—Parkinson's disease	2.36e-05	0.000101	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GSTM1—Parkinson's disease	2.31e-05	9.89e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CASP3—Parkinson's disease	2.27e-05	9.72e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—IL6—Parkinson's disease	2.26e-05	9.65e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GPX1—Parkinson's disease	2.21e-05	9.47e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MAPK8—Parkinson's disease	2.18e-05	9.33e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—INS—Parkinson's disease	2.15e-05	9.19e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—INS—Parkinson's disease	2.14e-05	9.16e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—INS—Parkinson's disease	2.12e-05	9.07e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MAPK8—Parkinson's disease	2.09e-05	8.93e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—MTHFR—Parkinson's disease	2.04e-05	8.74e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—APOE—Parkinson's disease	1.9e-05	8.14e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—INS—Parkinson's disease	1.62e-05	6.95e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	1.6e-05	6.84e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	1.59e-05	6.82e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	1.59e-05	6.8e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	1.58e-05	6.78e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	1.58e-05	6.75e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	1.57e-05	6.71e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	1.47e-05	6.29e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	1.46e-05	6.27e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	1.45e-05	6.21e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL6—Parkinson's disease	1.39e-05	5.96e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL6—Parkinson's disease	1.33e-05	5.7e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL6—Parkinson's disease	9.38e-06	4.02e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL6—Parkinson's disease	9.35e-06	4e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL6—Parkinson's disease	9.26e-06	3.96e-05	CbGpPWpGaD
